Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001079973-25-000599·Aptevo Therapeutics Inc.
Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock · CUSIP: 03835L306
Event date: 2025-04-02
- Filing-level shares
- 200,000.00
- Percent of class
- 6.21%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 200,000.00 · Class: 6.21%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000599
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Apr 07, 2025
- Reporting period
- Apr 02, 2025
- Description
- Schedule 13G beneficial ownership